Literature DB >> 22893398

Assessment of diabetic nephropathy in the Akita mouse.

Jae-Hyung Chang1, Susan B Gurley.   

Abstract

Akita mice have type 1 diabetes mellitus caused by a spontaneous point mutation in the Ins2 gene which leads to misfolding of insulin, resulting in pancreatic β-cell failure. Akita mice develop pronounced and sustained hyperglycemia, high levels of albuminuria, and consistent histopathological changes, suggesting that these mice may be suitable as an experimental platform for modeling diabetic nephropathy. One key feature of diabetic kidney disease in Akita mice is that the severity of renal injury is significantly influenced by genetic background. In this chapter, we describe the Akita model and present some of the experimental studies utilizing Akita mice as a model of type 1 diabetes. For example, deficiency in bradykinin receptors, endothelial nitric oxide synthase, or angiotensin-converting enzyme 2 leads to development of functionally and structurally more advanced diabetic nephropathy in these mice, while ketogenic diet has been shown to reverse kidney injury associated with diabetes. This chapter also describes the application of 24-h urine collections from mice for careful measurement of urinary albumin excretion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22893398     DOI: 10.1007/978-1-62703-068-7_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy.

Authors:  Jan Wysocki; Minghao Ye; Ahmed M Khattab; Agnes Fogo; Aline Martin; Nicolae Valentin David; Yashpal Kanwar; Mark Osborn; Daniel Batlle
Journal:  Kidney Int       Date:  2016-12-04       Impact factor: 10.612

Review 2.  The Prevalence and Management of Diabetic Nephropathy in Asia.

Authors:  Yasuhiko Tomino; Tomohito Gohda
Journal:  Kidney Dis (Basel)       Date:  2015-04-30

3.  Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice.

Authors:  Hongyu Zhang; Viji Nair; Jharna Saha; Kevin B Atkins; Jeffrey B Hodgin; Thomas L Saunders; Martin G Myers; Thomas Werner; Matthias Kretzler; Frank C Brosius
Journal:  Kidney Int       Date:  2017-05-26       Impact factor: 10.612

Review 4.  Sirtuin Family and Diabetic Kidney Disease.

Authors:  Che Bian; Huiwen Ren
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-14       Impact factor: 6.055

5.  Phosphorylation of ACTN4 Leads to Podocyte Vulnerability and Proteinuric Glomerulosclerosis.

Authors:  Di Feng; Mukesh Kumar; Jan Muntel; Susan B Gurley; Gabriel Birrane; Isaac E Stillman; Lai Ding; Minxian Wang; Saima Ahmed; Johannes Schlondorff; Seth L Alper; Tom Ferrante; Susan L Marquez; Carlos F Ng; Richard Novak; Donald E Ingber; Hanno Steen; Martin R Pollak
Journal:  J Am Soc Nephrol       Date:  2020-06-15       Impact factor: 10.121

6.  The altered renal and hepatic expression of solute carrier transporters (SLCs) in type 1 diabetic mice.

Authors:  Chenghao Xu; Ling Zhu; Ting Chan; Xiaoxi Lu; Weiyong Shen; Mark C Gillies; Fanfan Zhou
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

7.  Genetic modulation of diabetic nephropathy among mouse strains with Ins2 Akita mutation.

Authors:  Xiuju Wu; Richard C Davis; Timothy S McMillen; Valerie Schaeffer; Zhiqiang Zhou; Hongxiu Qi; Parisa N Mazandarani; Roshanak Alialy; Kelly L Hudkins; Aldons J Lusis; Renée C LeBoeuf
Journal:  Physiol Rep       Date:  2014-11-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.